Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15585230rdf:typepubmed:Citationlld:pubmed
pubmed-article:15585230lifeskim:mentionsumls-concept:C1304649lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0262950lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0021102lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0596973lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0205199lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C1705822lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C1704229lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C1705604lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0348011lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0549178lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0053629lld:lifeskim
pubmed-article:15585230lifeskim:mentionsumls-concept:C0137734lld:lifeskim
pubmed-article:15585230pubmed:issue15lld:pubmed
pubmed-article:15585230pubmed:dateCreated2004-12-8lld:pubmed
pubmed-article:15585230pubmed:abstractTextPoly(epsilon-caprolactone) (PCL)/continuous bioglass fibre composite was prepared using the monomer transfer moulding technique coupled with a surface initiated polymerisation. The bioglass fibres were surface treated with an amine ended silane in order to initiate polymerisation of epsilon-caprolactone from the fibre surface. Surface initiated polymerisation significantly improved the Young's modulus and flexural strength and water resistance of the composite. Initial in vitro biocompatibility assessment suggests that amine ended silane treatment of bioglass fibres before their inclusion in the composite does not have a negative effect on the biological responses in terms of macrophage activation as measured by IL-1beta release and craniofacial osteoblast attachment.lld:pubmed
pubmed-article:15585230pubmed:languageenglld:pubmed
pubmed-article:15585230pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585230pubmed:citationSubsetIMlld:pubmed
pubmed-article:15585230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585230pubmed:statusMEDLINElld:pubmed
pubmed-article:15585230pubmed:monthMaylld:pubmed
pubmed-article:15585230pubmed:issn0142-9612lld:pubmed
pubmed-article:15585230pubmed:authorpubmed-author:JonesI AIAlld:pubmed
pubmed-article:15585230pubmed:authorpubmed-author:EvansM EMElld:pubmed
pubmed-article:15585230pubmed:authorpubmed-author:ReedS CSClld:pubmed
pubmed-article:15585230pubmed:authorpubmed-author:WalkerG SGSlld:pubmed
pubmed-article:15585230pubmed:authorpubmed-author:ScotchfordC...lld:pubmed
pubmed-article:15585230pubmed:authorpubmed-author:JiangGGlld:pubmed
pubmed-article:15585230pubmed:issnTypePrintlld:pubmed
pubmed-article:15585230pubmed:volume26lld:pubmed
pubmed-article:15585230pubmed:ownerNLMlld:pubmed
pubmed-article:15585230pubmed:authorsCompleteYlld:pubmed
pubmed-article:15585230pubmed:pagination2281-8lld:pubmed
pubmed-article:15585230pubmed:dateRevised2008-8-14lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:meshHeadingpubmed-meshheading:15585230...lld:pubmed
pubmed-article:15585230pubmed:year2005lld:pubmed
pubmed-article:15585230pubmed:articleTitlePreparation of poly(epsilon-caprolactone)/continuous bioglass fibre composite using monomer transfer moulding for bone implant.lld:pubmed
pubmed-article:15585230pubmed:affiliationSchool of Mechanical, Materials, Manufacturing Engineering and Management, The University of Nottingham, University Park, Nottingham NG7 2RD, UK.lld:pubmed
pubmed-article:15585230pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15585230pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15585230pubmed:publicationTypeEvaluation Studieslld:pubmed